The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dual inhibition of PARP and ATR induces homologous recombination repair deficiency and leads to synthetic lethality in prostate cancer with CDK12 alteration.
 
Shusuke Akamatsu
Honoraria - Astellas Pharma; AstraZeneca/Hong Kong; Bayer; Janssen; Sanofi; Takeda
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Tosoh Corporation (Inst)
 
Yuki Kamiyama
No Relationships to Disclose
 
Takuro Sunada
No Relationships to Disclose
 
Kensuke Hikami
No Relationships to Disclose
 
Tomohiro Fukui
No Relationships to Disclose
 
Kei Mizuno
No Relationships to Disclose
 
Takayuki Sumiyoshi
No Relationships to Disclose
 
Takayuki Goto
Honoraria - Astellas Pharma; AstraZeneca
 
Takashi Kobayashi
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Janssen; Merck; MSD; Sanofi
Research Funding - AstraZeneca; Chugai Pharma
 
Hiroyuki Sasanuma
No Relationships to Disclose